Systemic immune-inflammatory index predicts all-cause and cardiovascular mortality in metabolic syndrome: A prospective cohort study using NHANES data
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Wu Jieping Medical Foundation (320.6750.2022-2-34)
- Natural Science Foundation of Beijing Municipality (L244067)
- National Natural Science Foundation of China (82202366)
This publication has 36 references indexed in Scilit:
- Machine Learning‐Assisted Analysis of Sublingual Microcirculatory Dysfunction for Early Cardiovascular Risk Evaluation and Cardiovascular‐Kidney‐Metabolic Syndrome Stage in Patients With Type 2 Diabetes MellitusDiabetes/Metabolism Research and Reviews, 2024
- Association between cumulative metabolic risk exposure and cardiovascular disease: a nationwide cohort of over 3.6 million young adultsEuropean Journal of Preventive Cardiology, 2024
- The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center studyCancer Immunology, Immunotherapy, 2022
- Molecular basis and therapeutic implications of CD40/CD40L immune checkpointPharmacology & Therapeutics, 2021
- Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery diseaseEuropean Journal of Clinical Investigation, 2020
- White Blood Cell Count and Total and Cause-Specific Mortality in the Women's Health InitiativeAmerican Journal of Epidemiology, 2017
- Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-AnalysisCancer Epidemiology, Biomarkers & Prevention, 2014
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease PredictionNew England Journal of Medicine, 2012
- Abdominal obesity and metabolic syndromeNature, 2006
- The metabolic syndromeThe Lancet, 2005